Dynamic Technology Lab Private Ltd Acquires Shares of 1,530 Teleflex Incorporated (NYSE:TFX)

Dynamic Technology Lab Private Ltd bought a new position in shares of Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,530 shares of the medical technology company’s stock, valued at approximately $272,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. HighTower Advisors LLC lifted its holdings in Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after buying an additional 66 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of Teleflex by 12.3% during the third quarter. Nomura Asset Management Co. Ltd. now owns 14,015 shares of the medical technology company’s stock worth $3,466,000 after acquiring an additional 1,533 shares during the last quarter. Public Employees Retirement System of Ohio lifted its stake in shares of Teleflex by 43.0% in the third quarter. Public Employees Retirement System of Ohio now owns 25,677 shares of the medical technology company’s stock worth $6,350,000 after acquiring an additional 7,721 shares in the last quarter. Barclays PLC boosted its holdings in Teleflex by 1.6% in the third quarter. Barclays PLC now owns 89,907 shares of the medical technology company’s stock valued at $22,233,000 after purchasing an additional 1,426 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock valued at $278,676,000 after purchasing an additional 5,746 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Price Performance

TFX opened at $129.10 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company’s 50-day moving average price is $148.90 and its 200 day moving average price is $182.33. Teleflex Incorporated has a fifty-two week low of $124.66 and a fifty-two week high of $249.91. The firm has a market cap of $5.99 billion, a price-to-earnings ratio of 25.67, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. As a group, sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on TFX. Wells Fargo & Company cut their target price on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Truist Financial decreased their price objective on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a report on Monday, March 3rd. Morgan Stanley cut their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 5th. Finally, StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.